Fexinidazole

Overview

Fexinidazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1631694).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Fexinidazole expires — and exclusivity 16 Jul 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-methyl-2-[(4-methylsulfanylphenoxy)methyl]-5-nitroimidazole

Canonical SMILES

CN1C(=CN=C1COC2=CC=C(C=C2)SC)[N+](=O)[O-]

InChIKey

MIWWSGDADVMLTG-UHFFFAOYSA-N